News Focus
News Focus
icon url

tm100

01/11/20 11:47 AM

#240102 RE: Biobillionair #240098


Don’t be surprised if TEVA owns AMARIN before 2029


I have wondered about that possibility. Why would amrn give up market early to Teva? Being bought or merged was only explanation that makes sense to me.

icon url

mrmainstreet

01/11/20 2:49 PM

#240134 RE: Biobillionair #240098

BB, I think you're insane as you know, but I do appreciate your legal DD as it's incredibly valuable to the board.

Can I ask you, or any others who would like to opine, does Judge Du presiding over the TEVA case (which settled) have any impact on how she will see this new case?

Aren't many of the arguments/facts the same? Just wondering how it might affect her judgment either way.

Thanks
icon url

io_io

01/12/20 3:45 PM

#240311 RE: Biobillionair #240098

That’s up to the full scope of TEVA settlement and it’s not public information. BB

The deal with TEVA is public information, and its crystal clear - TEVA gets to market a generic 6 to 8 months before the Marine patents expire - check the press release wording or 10-K filing.

That of means that AMRN undertook not to put any legal obstacles in TEVA's path - such as by asserting old or new patents, etc.